Register Cart 0

Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back Subscribe

Editorial

Editorial (Thematic Issue: Perspectives and Challenges in Rational Exploitation of Phytochemicals in Cure, Control and Management of Diseases)

Author(s): Jayant Shankar Raut, Parneet Kaur Deol and Indu Pal Kaur

Volume 22, Issue 27, 2016

Page: [4095 - 4097] Pages: 3

DOI: 10.2174/1381612822999160624100330

Next »

Rights & Permissions Print Export Cite as

Article Metrics

34

Journal Information

For Authors & Reviewers

Explore Articles

Open Access

For Visitors

Related Articles

The Interactions of Anticancer Agents with Tea Catechins: Current Evidence from Preclinical Studies
Anti-Cancer Agents in Medicinal Chemistry

Pathway Analysis for Design of Promiscuous Drugs and Selective Drug Mixtures
Current Drug Discovery Technologies

Dysregulation of SIRT-1 Signaling in Multiple Sclerosis and Neuroimmune Disorders: A Systematic Review of SIRTUIN Activators as Potential Immunomodulators and their Influences on other Dysfunctions
Endocrine, Metabolic & Immune Disorders - Drug Targets

Preparation, Characterization, and In Vitro Release of Vinorelbine Tartrate (VLBT)- Loaded Folate-conjugated Recombination Human Serum Albumin (rHSA) Nanoparticles with Different Degree of Cross-linking
Current Nanoscience

microRNAs as Anti-Cancer Therapy
Current Pharmaceutical Design

The Small Heat Shock Protein HspB8: Role in Nervous System Physiology and Pathology
CNS & Neurological Disorders - Drug Targets

Antiprotozoal Agents: An Overview
Anti-Infective Agents in Medicinal Chemistry

PEDF & Stem Cells: Niche vs. Nurture
Current Drug Delivery

The Use of Human Albumin for the Treatment of Ascites in Patients with Liver Cirrhosis: Item of Safety, Facts, Controversies and Perspectives
Current Drug Safety

Emerging Therapies for Type 2 Diabetes
Current Drug Therapy

Screening for Inhibitors of Microglia to Reduce Neuroinflammation
CNS & Neurological Disorders - Drug Targets

The Changing Landscape of Voltage-Gated Calcium Channels in Neurovascular Disorders and in Neurodegenerative Diseases
Current Neuropharmacology

Inhibition of the Calcineurin-NFAT Signalling Cascade in the Treatment of Heart Failure
Recent Patents on Cardiovascular Drug Discovery

Actions of Rho-Kinase Inhibitors in Cardiovascular Diseases
Current Enzyme Inhibition

p38 MAP Kinase Mediated Proteoglycan Synthesis as a Target for the Prevention of Atherosclerosis
Cardiovascular & Hematological Disorders-Drug Targets

Apoptosis Imaging to Monitor Cancer Therapy: The Road to Fast Treatment Evaluation?
Current Pharmaceutical Biotechnology

Fatty Acids - Induced Lipotoxicity and Inflammation
Current Drug Metabolism

Alogliptin: a Novel Molecule for Improving Glycemic Control in Type II Diabetes Mellitus
Current Diabetes Reviews

Models to Study Atherosclerosis: A Mechanistic Insight
Current Vascular Pharmacology

Stroke Risk Stratification Schemes in Atrial Fibrillation in the Era of Non- Vitamin K Anticoagulants: Misleading and Obsolete, At Least for the “Low-Risk” Patients?
Current Drug Targets

© 2023 Bentham Science Publishers | Privacy Policy